Proteomic profiling of hyperplasia/atypia and adenoma-induced by NNK in mouse lung identified multiple proteins as potential biomarkers for early detection

Abstract We used a proteomics approach (iTRAQ) to identify differentially expressed lung proteins during early stages of the tobacco carcinogen, NNK-induced lung tumorigenesis (hyperplasia/atypia, 4–10 weeks and adenoma, 25 week) prior to the detection of adenocarcinoma in A/J mice. We identified 790 proteins at week 4 and 710 proteins at weeks 10 and 25 with >95% confidence and a Local False Discovery Rate estimation less than 5%. We have demonstrated that NNK altered multiple protein (e.g., Carbonyl Reductase, Annexin A5/6, Selenbp1, Hmgb1 and Hsp90b1) expressions in early lesions which can be used as potential biomarkers for early detection of lung cancer.

[1]  M. You,et al.  Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas , 2004, Oncogene.

[2]  S. Hecht,et al.  It Is Time to Regulate Carcinogenic Tobacco-Specific Nitrosamines in Cigarette Tobacco , 2014, Cancer Prevention Research.

[3]  S. Hecht,et al.  More than 500 trillion molecules of strong carcinogens per cigarette: use in product labelling? , 2011, Tobacco Control.

[4]  Y. Miller,et al.  Lung cancer chemoprevention: current status and future prospects , 2013, Nature Reviews Clinical Oncology.

[5]  M. You,et al.  DETECTION OF DIFFERENTIALLY EXPRESSED GENES IN MOUSE LUNG ADENOCARCINOMAS , 2001, Experimental lung research.

[6]  Z. Naito,et al.  Expression and Roles of Heat Shock Proteins in Human Breast Cancer , 1996, Japanese journal of cancer research : Gann.

[7]  Stephen S. Hecht,et al.  Chemoprevention of lung carcinogenesis in addicted smokers and ex-smokers , 2009, Nature Reviews Cancer.

[8]  John A Thompson,et al.  Carbonyl reductase inactivation may contribute to mouse lung tumor promotion by electrophilic metabolites of butylated hydroxytoluene: protein alkylation in vivo and in vitro. , 2008, Chemical research in toxicology.

[9]  David E. Misek,et al.  Reduced selenium‐binding protein 1 expression is associated with poor outcome in lung adenocarcinomas , 2004, The Journal of pathology.

[10]  Jie Liao,et al.  Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. , 2006, Cancer research.

[11]  Rong Biaoxue,et al.  Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients , 2012, Journal of experimental & clinical cancer research : CR.

[12]  S. Amin,et al.  The organoselenium compound 1,4-phenylenebis(methylene)selenocyanate inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorgenesis and enhances glutathione-related antioxidant levels in A/J mouse lung. , 2006, Chemico-biological interactions.

[13]  J. Borlak,et al.  Towards a lung adenocarcinoma proteome map: Studies with SP‐C/c‐raf transgenic mice , 2006, Proteomics.

[14]  T. Kondo,et al.  Decreased Selenium-Binding Protein 1 Enhances Glutathione Peroxidase 1 Activity and Downregulates HIF-1α to Promote Hepatocellular Carcinoma Invasiveness , 2012, Clinical Cancer Research.

[15]  R. Enck,et al.  Lung cancer: diagnosis and management. , 2007, American family physician.

[16]  Guanghui Wang,et al.  Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. , 2006, Journal of proteome research.

[17]  A. Malkinson.  Molecular comparison of human and mouse pulmonary adenocarcinomas. , 1998, Experimental lung research.

[18]  I. Wistuba,et al.  Smoking molecular damage in bronchial epithelium , 2002, Oncogene.

[19]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[20]  R. Donato,et al.  The Amphoterin (HMGB1)/Receptor for Advanced Glycation End Products (RAGE) Pair Modulates Myoblast Proliferation, Apoptosis, Adhesiveness, Migration, and Invasiveness , 2006, Journal of Biological Chemistry.

[21]  S. Amin,et al.  Comparison of the Chemopreventive Efficacies of 1,4-phenylenebis(methylene)selenocyanate and Selenium-Enriched Yeast on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone Induced Lung Tumorigenesis in A/J Mouse , 2003, Nutrition and cancer.

[22]  K. El-Bayoumy.  Effects of organoselenium compounds on induction of mouse forestomach tumors by benzo(a)pyrene. , 1985, Cancer research.

[23]  Arunangshu Das,et al.  Down-regulation of 14-3-3 isoforms and annexin A5 proteins in lung adenocarcinoma induced by the tobacco-specific nitrosamine NNK in the A/J mouse revealed by proteomic analysis. , 2009, Journal of proteome research.

[24]  G. Yang,et al.  Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model with A/J mice. , 1997, Cancer research.

[25]  T. Kislinger,et al.  Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.

[26]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[27]  T. Devereux,et al.  Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer , 2007, Toxicologic pathology.

[28]  D. Petersen,et al.  Human carbonyl reductase catalyzes reduction of 4-oxonon-2-enal. , 2004, Biochemistry.

[29]  Chronic Disease Division.  Cancer facts and figures , 2010 .

[30]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[31]  A. Porat,et al.  A 56-kDa Selenium-binding Protein Participates in Intra-Golgi Protein Transport* , 2000, The Journal of Biological Chemistry.

[32]  K. Parker,et al.  Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging Reagents*S , 2004, Molecular & Cellular Proteomics.

[33]  Yong-mei Song,et al.  The expression of high-mobility group protein box 1 correlates with the progression of non-small cell lung cancer. , 2009, Oncology reports.

[34]  G. Bergman,et al.  Preclinical and clinical models of lung cancer chemoprevention. , 1998, Hematology/oncology clinics of North America.

[35]  Jason Liao,et al.  Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. , 2011, Journal of proteome research.

[36]  Lennart Martens,et al.  The minimum information about a proteomics experiment (MIAPE) , 2007, Nature Biotechnology.

[37]  Sean L Seymour,et al.  Nonlinear fitting method for determining local false discovery rates from decoy database searches. , 2008, Journal of proteome research.

[38]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[39]  M. Bianchi,et al.  HMGB proteins and gene expression. , 2003, Current opinion in genetics & development.

[40]  S. Amin,et al.  Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and the effect of diet. , 1989, Carcinogenesis.

[41]  S. Tsuchida,et al.  Carbonyl reductase: a novel metastasis-modulating function. , 2000, Cancer research.

[42]  R. Cardiff,et al.  Classification of Proliferative Pulmonary Lesions of the Mouse , 2004, Cancer Research.

[43]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[44]  P. Csermely,et al.  Hsp90 isoforms: functions, expression and clinical importance , 2004, FEBS letters.

[45]  S. Hecht,et al.  Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice. , 2007, Carcinogenesis.

[46]  Zhongzhou He,et al.  Overexpression of endoplasmic reticulum molecular chaperone GRP94 and GRP78 in human lung cancer tissues and its significance. , 2005, Cancer Detection and Prevention.

[47]  H. Wada,et al.  Carbonyl Reductase Expression and Its Clinical Significance in Non–Small-Cell Lung Cancer , 2005, Cancer Epidemiology, Biomarkers and Prevention.